Literature DB >> 25045635

Is elective neck dissection needed in clinically N0 neck in maxillary cancer?

Hong-Ju Park1.   

Abstract

Entities:  

Year:  2014        PMID: 25045635      PMCID: PMC4095808          DOI: 10.5125/jkaoms.2014.40.3.101

Source DB:  PubMed          Journal:  J Korean Assoc Oral Maxillofac Surg        ISSN: 1225-1585


× No keyword cloud information.
Maxillary cancer can be classified according to its primary site. In the literature, many authors divide maxillary cancer into carcinomas of the oral mucosa (gingiva, alveolus and hard palate), and carcinomas of the maxillary sinus and nasal cavity malignancies1,2,3,4. The incidence of neck node metastasis was reported to be 3% to 26% and 12% to 29% in the maxillary sinus and oral mucosa, respectively1,4,5,6,7,8,9,10,11. Recent studies have demonstrated that the incidence of regional metastasis of squamous cell carcinoma (SCC) of the upper gingiva, alveolus and hard palate is similar to that of the tongue and mouth floor5,6,7,8. The traditional management of clinically N0 neck in maxillary cancer has been to wait and see, and this strategy has been widely accepted. Elective neck dissection in clinically N0 neck in maxillary cancer remains controversial. There have been no prospective studies on this topic because of the rarity of maxillary cancer. It is widely accepted that neck dissection is the best course of treatment for maxillary cancer if the possibility of neck metastasis is greater than 15% to 20%12,13,14. In SCC of the hard palate, maxillary gingiva and alveolus, Montes and Schmidt6 demonstrated a 27% regional failure rate in clinically N0 neck after primary resection. Simental et al.5 reported the occult metastasis rate of SCC to be 29% in the maxillary gingiva, alveolus, and hard palate. Yorozu et al.8 found the occult metastasis rate of SCC in the hard palate to be 21%. In patients with maxillary sinus cancer, Kim et al.15 reported 13.5% occult metastasis in those who did not receive elective neck dissection at the time of primary resection. Le et al.4 described a 5-year nodal relapse rate of 20% in N0 neck of maxillary sinus carcinoma without elective neck control at the time of or after surgery, while this rate was reduced to 0% with elective neck irradiation after surgery. Many studies have reported that occult metastasis of cancers of the oral mucosa of the maxilla is more common than it is in cancers of the maxillary sinus. However, there have been no randomized prospective studies regarding occult metastasis of these cancers. Traditionally, elective neck dissection of clinically N0 neck is delayed after primary resection of maxillary cancer. Recently, many authors have agreed that regional metastasis of maxillary cancer is aggressive and comparable to cancers of tongue and mouth floor1,5,6,7. Consequently, they recommend elective neck dissection at the time of primary tumor resection. Simental et al.5 noted that maxillary cancer of the hard palate and alveolus behave like lower gingival cancer, not like sinonasal cancer, and drained level I, II, and III. Also, the rate of occult metastasis of maxillary oral mucosa cancer is very high, and most recent reports have recommended elective neck dissection in N0 neck2,3,5,7,8,10,12,13. Salvage surgery may be unsuccessful in cases of regional failure after primary resection. Elective neck dissection is highly recommended in cancers of the maxillary gingiva, alveolus, and hard palate for regional control. Elective neck dissection is also recommended in cases of locally-advanced maxillary sinus cancer. For regional control, many authors suggest that elective neck dissection is better than radiation therapy, because salvage surgery after radiation therapy can be very difficult2,3,5,7,12,13,14.
  15 in total

1.  Maxillary bone invasion by gingival carcinoma as an indicator of cervical metastasis.

Authors:  I Ogura; T Kurabayashi; T Sasaki; T Amagasa; N Okada; T Kaneda
Journal:  Dentomaxillofac Radiol       Date:  2003-09       Impact factor: 2.419

2.  Lymph node metastasis in maxillary sinus carcinoma.

Authors:  Q T Le; K K Fu; M J Kaplan; D J Terris; W E Fee; D R Goffinet
Journal:  Int J Radiat Oncol Biol Phys       Date:  2000-02-01       Impact factor: 7.038

3.  Carcinoma of the hard palate treated with radiotherapy: a retrospective review of 31 cases.

Authors:  A Yorozu; A J Sykes; N J Slevin
Journal:  Oral Oncol       Date:  2001-09       Impact factor: 5.337

4.  Elective neck dissection versus observation for cN0 neck of squamous cell carcinoma primarily located in the maxillary gingiva and alveolar ridge: a retrospective study of 129 cases.

Authors:  Zhien Feng; Jian Nan Li; Chuan Zhen Li; Chuan Bin Guo
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol       Date:  2013-11

Review 5.  Is prophylactic neck irradiation indicated in patients with squamous cell carcinoma of the maxillary sinus?

Authors:  A C Paulino; S G Fisher; J E Marks
Journal:  Int J Radiat Oncol Biol Phys       Date:  1997-09-01       Impact factor: 7.038

6.  Improved survival for patients with clinically T1/T2, N0 tongue tumors undergoing a prophylactic neck dissection.

Authors:  K J Haddadin; D S Soutar; R J Oliver; M H Webster; A G Robertson; D G MacDonald
Journal:  Head Neck       Date:  1999-09       Impact factor: 3.147

7.  Squamous cell carcinoma of the maxillary gingiva, alveolus, and hard palate: is there a need for elective neck dissection?

Authors:  Constantinos Mourouzis; Clive Pratt; Peter A Brennan
Journal:  Br J Oral Maxillofac Surg       Date:  2009-08-07       Impact factor: 1.651

8.  Anatomical site and size of 222 early asymptomatic oral squamous cell carcinomas: a continuing prospective study of oral cancer. II.

Authors:  A Mashberg; H Meyers
Journal:  Cancer       Date:  1976-05       Impact factor: 6.860

9.  Clinical significance of neck node metastasis in squamous cell carcinoma of the maxillary antrum.

Authors:  G E Kim; E J Chung; J J Lim; K C Keum; S W Lee; J H Cho; C G Lee; E C Choi
Journal:  Am J Otolaryngol       Date:  1999 Nov-Dec       Impact factor: 1.808

Review 10.  Oral maxillary squamous cell carcinoma: management of the clinically negative neck.

Authors:  David M Montes; Brian L Schmidt
Journal:  J Oral Maxillofac Surg       Date:  2008-04       Impact factor: 1.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.